| Virginia Merritt, MD | |
|
63 Fountain St Ste 402, Framingham, MA 01702-6280 | |
| (508) 872-4813 | |
| Not Available |
| Full Name | Virginia Merritt |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 63 Fountain St Ste 402, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891804555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 60346 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Psychiatric Services Llc | 4082983911 | 8 |
News Archive
Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.
Dr. Nicole Gullo is a New York City-based metabolism expert and board-certified chiropractic physician offering consumers the ultimate stimulus package: Good health.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
Patient Safety is a Priority in Europe and has improved over the years. Nevertheless, every year between 8 and 12% of the people admitted to hospitals and around 6% of those in primary care suffer from an adverse event (AE) while receiving healthcare.
Prenatal exposure to an insecticide commonly used up until the 1970s may play a role in the obesity epidemic in women, according to a new study involving several Michigan State University researchers.
› Verified 4 days ago
| Entity Name | Massachusetts Psychiatric Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265989453 PECOS PAC ID: 4082983911 Enrollment ID: O20170707001594 |
News Archive
Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.
Dr. Nicole Gullo is a New York City-based metabolism expert and board-certified chiropractic physician offering consumers the ultimate stimulus package: Good health.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
Patient Safety is a Priority in Europe and has improved over the years. Nevertheless, every year between 8 and 12% of the people admitted to hospitals and around 6% of those in primary care suffer from an adverse event (AE) while receiving healthcare.
Prenatal exposure to an insecticide commonly used up until the 1970s may play a role in the obesity epidemic in women, according to a new study involving several Michigan State University researchers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Merritt, MD 190 Jackson St, Newton Center, MA 02459-2540 Ph: (617) 969-5493 | Virginia Merritt, MD 63 Fountain St Ste 402, Framingham, MA 01702-6280 Ph: (508) 872-4813 |
News Archive
Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.
Dr. Nicole Gullo is a New York City-based metabolism expert and board-certified chiropractic physician offering consumers the ultimate stimulus package: Good health.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
Patient Safety is a Priority in Europe and has improved over the years. Nevertheless, every year between 8 and 12% of the people admitted to hospitals and around 6% of those in primary care suffer from an adverse event (AE) while receiving healthcare.
Prenatal exposure to an insecticide commonly used up until the 1970s may play a role in the obesity epidemic in women, according to a new study involving several Michigan State University researchers.
› Verified 4 days ago
Joseph G. D'alton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 463 Worcester Rd, Suite 101, Framingham, MA 01701 Phone: 508-820-0469 Fax: 508-626-1985 | |
Adriana Neagoe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 945 Concord St, Framingham, MA 01701 Phone: 508-283-7898 Fax: 508-764-2462 | |
Ashley Lee Shepard, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 201, Framingham, MA 01702 Phone: 508-845-1110 | |
Dr. Sean Orin Mackintosh, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Frederick Abbott Way, Framingham, MA 01701 Phone: 508-879-9800 Fax: 508-875-1348 | |
Dr. James Allen Kennedy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 88 Lincoln St, Framingham, MA 01702 Phone: 508-879-9800 | |
Robert Merle Johnston, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 354 Waverly St, Advocates Inc., Framingham, MA 01702 Phone: 508-661-2020 | |
Dr. Jacob Goldberg, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 359 Union Ave, Framingham, MA 01702 Phone: 508-620-1919 Fax: 508-820-3093 |